Venus Remedies Share Price
Small Cap | Pharmaceuticals and health care | NSE: VENUSREM | BSE: 526953
₹290.75 
-1.20 (-0.41 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 292.40
High (₹) 294.70
Low (₹) 288.90
Prev. Close (₹) 291.95
Volume 2,052
VWAP (₹) 301.19
ROCE (%) 8.17
Industry P/E 43.95
TTM P/E 11.15
P/B Ratio 0.80
Market Cap (₹) Cr.388.18
Dividend Yield (%)--
EPS (₹) 21.31
ROE5.84%
Sales Growth (%) 8.27
Profit Growth (%)7.25
Day Range
294.70294.70
52 Week Range
272.20427.30
Historical Returns
Returns (6M)
-17.99 %
Returns (1Y)
-5 %
Returns (3Y)
-8.03 %
Returns (5Y)
804.35 %
Returns (6M)
-17.99 %
Returns (1Y)
-5 %
Returns (3Y)
-8.03 %
Returns (5Y)
804.35 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (7.19%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 7.19% positive TTM EPS growth
- Growth in Net Profit Margin (QoQ)
Technicals
Technical Rating
BEARISHRSI 34.09
MFI 14.75
ATR 20.76
Commodity Channel Index -89.53
ROC125 -14.81
ROC21 0.39
Williams %R -99.39
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 301.51 | 306.83 | 309.71 | 298.63 | 293.31 | 290.43 | 285.11 |
| Week Ago | 314.80 | 319.95 | 322.60 | 312.15 | 307.00 | 304.35 | 299.20 |
| Month Ago | 283.94 | 290.87 | 296.74 | 278.07 | 271.14 | 265.27 | 258.34 |
EMA & SMA
290.75
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 307.51
9 Day 306.92
10 Day 309.80
12 Day 310.67
14 Day 319.30
20 Day 314.52
26 Day 308.96
50 Day 308.97
100 Day 315.10
200 Day 334.24
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 31 May, 2022 | PAWAN CHAUDHARY | Acquisition | ₹217.31 | 1,26,946 | BSE |
| 20 Sept, 2021 | PAWAN CHAUDHARY Revised | Acquisition | ₹10.00 | 6,00,000 | BSE |
| 20 Sept, 2021 | MANU CHAUDHARY Revised | Acquisition | ₹10.00 | 4,25,000 | BSE |
| 04 Jun, 2021 | Pawan Chaudhary | Acquisition | ₹ | 6,00,000 | BSE |
| 04 Jun, 2021 | Manu Chaudhary | Acquisition | ₹ | 4,25,000 | BSE |
| 25 Feb, 2021 | MANU CHAUDHARY | Acquisition | ₹10.00 | 4,25,000 | BSE |
| 25 Feb, 2021 | PAWAN CHAUDHARY | Acquisition | ₹10.00 | 6,00,000 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 25 Feb, 2025 | NSE India | Venus Remedies Limited has informed the Exchange regarding '' Venus Remedies Secures Exclusive In-Licensing Rights from Infex Therapeutics to Develop and Commercialize MET-X in India''. |
| 25 Feb, 2025 | BSE India | Venus Remedies secures exclusive In-Licensing rights from Infex Therapeutics to develop and commercialize MET-X in India |
| 10 Feb, 2025 | NSE India | Venus Remedies Limited has informed the Exchange regarding ''Venus Remedies gets Marketing Authorization for anticoagulant Enoxaparin from Indonesia ''. |
| 10 Feb, 2025 | BSE India | Venus Remedies gets Market Authorization for anticoagulant Enoxaparin from Indonesia |
| 06 Feb, 2025 | NSE India | Venus Remedies Limited has informed the Exchange about Copy of Newspaper Publication |
| 05 Feb, 2025 | NSE India | Integrated Filing of Unaudited Financial results for the period ended on 31st December 2024. |
| 05 Feb, 2025 | BSE India | Integrated filing of Unaudited Financial results for the period ended on 31st December 2024. |
| 04 Feb, 2025 | NSE India | Venus Remedies Limited has informed the Exchange regarding ''''Intimation under Regulation 30 |
| 04 Feb, 2025 | BSE India | Intimation under Regulation 30 |
| 04 Feb, 2025 | BSE India | Unaudited financial results as on 31.12.2024 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 25 Jan, 2025 | 04 Feb, 2025 |
| Quarterly Results | -- | 21 Oct, 2024 | 29 Oct, 2024 |
| Quarterly Results & A.G.M. | -- | 02 Aug, 2024 | 13 Aug, 2024 |
| Others | 1. To consider the appointment of independent director. 2. To finalize the date of 35th Annual General Meeting of the company. | 20 Jul, 2024 | 20 Jul, 2024 |
| Audited Results | -- | 22 May, 2024 | 30 May, 2024 |
| Quarterly Results | -- | 05 Feb, 2024 | 14 Feb, 2024 |
| Quarterly Results | -- | 31 Oct, 2023 | 09 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 14 Aug, 2023 |
| Others | -- | 06 Jul, 2023 | 14 Jul, 2023 |
| Audited Results | -- | 18 May, 2023 | 29 May, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Venus Remedies
Venus Remedies is a Public Limited Listed company incorporated on 15/09/1989 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1989PLC009705 and registration number is 009705. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 575.21 Cr. and Equity Capital is Rs. 13.37 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1989
Managing Director
Mr. Pawan Chaudhary
NSE Symbol
VENUSREM
Venus Remedies Management
| Name | Designation |
|---|---|
| Mr. Pawan Chaudhary | Chairman & Managing Director |
| Dr.(Mrs.) Manu Chaudhary | Joint Managing Director |
| Mr. Peeyush Jain | Deputy Managing Director |
| Mr. Ashutosh Jain | Executive Director |
| Mr. Akshansh Chaudhary | Executive Director |
| Dr.(Mrs.) Savita Gupta | Independent Director |
| Mr. N P S Monga | Independent Director |
| Mr. Navdeep Sud | Independent Director |
| Dr. Gilbert Wenzel | Independent Director |
| Dr. S K Chadha | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Venus Remedies
What is the share price of Venus Remedies?
The share price of Venus Remedies on 13 Mar, 2025 is ₹ 290.75.
What is 52W high and 52W low share price of Venus Remedies?
The highest and lowest 52W share prices of Venus Remedies are ₹ 427.300 and ₹ 272.200
What is the market cap of Venus Remedies?
The market capitalization of Venus Remedies as of 13 Mar, 2025 is ₹ 388.18 Crores
What is the P/E ratio of Venus Remedies?
The current P/E ratio of Venus Remedies as of 13 Mar, 2025 is 43.95
What is the PB ratio of Venus Remedies?
The PB ratio of Venus Remedies as of 13 Mar, 2025 is 0.80
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)